• Logo

    The Global Fund Board has decided that all AMFm co-paid ACTs should bear a logo (the ‘universal logo’) to facilitate communication campaigns and product identification. The Global Fund is working with partners to facilitate the design and development of this universal logo which will be applied to all quality-assured ACTs purchased through AMFm. The purpose of the logo will be to:

    1. Enable the marketer/distributor to communicate the affordability and effectiveness of AMFm co-paid ACTs

    2. Enable providers, retailers, and end-users seeking treatment to easily recognize the quality-assured, affordable, AMFm co-paid ACTs

    3. Enable the independent evaluation to more easily collect data on affordability, availability, market share and use of co-paid ACTs

    4. Facilitate the identification of those drugs that have leaked across borders to non-AMFm countries